CDK2 and benign prostatic hyperplasia: Consistent with data obtained from the Western blot analysis, results from RT-qPCR data revealed that the treatment of BPH-1 cells with COFE downregulated the Cyclin E/A-CDK2 and Cyclin D-CDK4 mRNA expression and regulated RB/E2F1 mRNA expression (Figure 2F).